Niels Hellings

16PUBLICATIONS
56CO-AUTHORS
Cellular immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 23, 2026
Cytomegalovirus Drives the Development of Cytotoxic CD4+ T Cells in Patients With Multiple Sclerosis.

Cindy Hoeks, Bram Boeckx, Paulien Baeten

|Mar 16, 2026
The human TIMP-1 unbound structure provides a platform for fragment screening.

Ahmed Shemy, Jana Van Broeckhoven, Niels Hellings

|Jan 28, 2026
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.

Naomi Veeningen, Ana Laura Añé-Kourí, Astrid Pues

|Jan 14, 2026
Targeting Epstein-Barr virus is a viable therapeutic strategy in multiple sclerosis: No.

Niels Hellings

|Jul 30, 2025
Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity.

Raul Ramos Pupo, Laura M Reyes Diaz, Gisela M Suarez Formigo

|Nov 16, 2024
A new player in the game: identification of C1ql1 as a novel factor driving OPC differentiation.

Jana Van Broeckhoven, Femke Mussen, Melissa Schepers

Pageof 3

Frequent Collaborators

5 joint publications

Jana Van Broeckhoven

4 joint publications

Tim Vanmierlo

2 joint publications

Raf Donders

2 joint publications

Veerle Somers